Bookedited by Michele I Morris, Camille Nelson Kotton, Camille Wolfe.
Summary: This updateable reference work is designed to meet the needs of practitioners engaged in transplant infectious disease practice who need immediate access to current and reputable resources. It provides an overview of emerging infectious disease challenges with clinically relevant information regarding the epidemiology, diagnosis, management, and prevention of infections in solid organ and stem cell transplant recipients. Each chapter focuses on a clinical syndrome or pathogen with new or emerging implications for transplant patients. Sections include coverage on viral, bacterial, parasitic, and fungal infections, special diagnostic considerations, epidemiology, and other vital challenges physicians must face as new infections emerge. Written by international experts in emerging and transplant infections, Emerging Transplant Infections is the ultimate resource for any clinicians treating transplant patients in the era of rapidly evolving infections, including infectious disease specialists, transplant physicians, tropical medicine specialists, hematologists, oncologists, emergency physicians, hospitalists, primary care specialists, and all others.
Contents:
Infectious Diseases
impact of infections on transplant morbidity/mortality, data on ID impact on outcomes, and important role of Infectious Disease providers in the transplant team
Intro to Solid Organ Transplant
Intro to Stem Cell Transplantation
General concepts
Hospital epi / InfControl issues
Antibiotic Stewardship for transplant ID
Prophylaxis in the era of emerging new infectious pathogens
Pre-transplant evaluation of patients with MDRO infection/colonization
Pre-transplant screening of patients with epidemiologic & geographic risk factors for infection exposure
Safe living post-transplant
Vaccination
Travel medicine and the Transplant Recipient
Infection Avoidance & Management of the Returning Traveler with Fever including Transplant Tourism
Changing definition of Immunosuppression
Biologics, Monoclonal Antibodies
what infections will emerge as a result and how do we prevent them?
Multidrug Resistant Organisms including Extended Spectrum Beta Lactamase Producing Organisms & Carbapenemase Resistant Enterobacteriaceae
Mycobacterium tuberculosis
Rapidly Growing Nontuberculous Mycobacteria
Slow Growing Nontuberculous Mycobacteria
Nocardia
Mycoplasma / Ureaplasma
Pseudomonas including Pseudomonas pseudomallei
Acinetobacter
Burkholderia
Clostridia Difficile
Cytomegalovirus
Herpes Simplex
Varicella Zoster
Epstein Barr Virus including PTLD
HHV6, HHV7, HHV8
BK Virus
Influenza
Respiratory Syncytial Virus
Respiratory viruses including parainfluenza, metapneumovirus, rhinovirus, enterovirus, coronaviruses (MERS CoV & SARS)
Adenovirus
HIV
Hepatitis A & E
Hepatitis B & D
Hepatitis C
West Nile Virus
Dengue, Chikungunya, & Zika
Yellow Fever
Viral Encephalitides including Rabies & Lymphocytic Choriomeningitis Virus
Candida
Aspergillus
Mucorales
Non-Aspergillus Molds esp. Phaeohyphomycoses
Cryptococcus including gatti
Pneumocystis
Endemic molds
coccidioidomycosis, histoplasmosis, blastomycosis, paracoccidioidomycosis
Toxoplasmosis
Strongyloidiasis
Chagas disease
Leishmaniasis
Malaria
Entamoeba histolytica
Intestinal Parasites including Cryptosporidium, Cyclospora, Microsporidia, Blastocystis hominis, Isospora, Giardia
Acanthamoeba, Naegleria, & Balamuthia
Ventricular Assist Devices/ECMO/Cardiac Support
Infection in Vascular Composite Allografts
Rash
Eye infections
Pulmonary
Diarrhea
Encephalitis & Delerium
Cytopenias including Anemia and Neutropenic Fever.
Continuously updated edition